# Randall Winnette

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/randall-winnette/

## Facts

| Field | Value |
| --- | --- |
| Citations | 459 |
| Field | Hair Growth and Disorders |
| h-index | 9 |
| i10-index | 9 |
| Last Known Institution | Novartis (United States) |
| OpenAlex ID | https://openalex.org/A5075740717 |
| ORCID iD | 0000-0002-1617-967X |
| Works | 29 |

## Researcher papers

- [Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) Measure](https://scholariq.org/papers/development-of-the-exacerbations-of-chronic-obstructive-pulmonary-disease-tool/)
- [Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review](https://scholariq.org/papers/patient-perspectives-of-the-social-emotional-and-functional-impact-of-alopecia/)
- [Efficacy and Safety of the <scp>TYK2</scp>/<scp>JAK1</scp> Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase <scp>IIb</scp> Randomized Controlled Trial](https://scholariq.org/papers/efficacy-and-safety-of-the-scp-tyk2-scp-scp-jak1-scp-inhibitor-brepocitinib-for/)
- [The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature](https://scholariq.org/papers/the-patient-experience-with-soft-tissue-sarcoma-a-systematic-review-of-the/)
- [Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata](https://scholariq.org/papers/validation-of-the-alopecia-areata-patient-priority-outcomes-aappo-questionnaire/)
- [Characterizing the relationships between patient‐reported outcomes and clinician assessments of alopecia areata in a phase 2a randomized trial of ritlecitinib and brepocitinib](https://scholariq.org/papers/characterizing-the-relationships-between-patient-reported-outcomes-and-clinician/)
- [Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study](https://scholariq.org/papers/development-of-the-alopecia-areata-patient-priority-outcomes-instrument-a/)
- [Capturing patients' perspectives of treatment in clinical trials/drug development](https://scholariq.org/papers/capturing-patients-perspectives-of-treatment-in-clinical-trials-drug-development/)
- [A Review of Labeling Based on Patient-Reported Outcome Endpoints for New Oncology Drugs Approved by the European Medicines Agency (2017-2021)](https://scholariq.org/papers/a-review-of-labeling-based-on-patient-reported-outcome-endpoints-for-new/)
- [Resource utilization and productivity loss in persons with spina bifida − an observational study of patients in a tertiary urology clinic in <scp>G</scp>ermany](https://scholariq.org/papers/resource-utilization-and-productivity-loss-in-persons-with-spina-bifida-an/)
- [Development of a Conceptual Model for the Patient Experience of Immunoglobulin A Nephropathy (IgAN): A Qualitative Literature Review](https://scholariq.org/papers/development-of-a-conceptual-model-for-the-patient-experience-of-immunoglobulin-a/)

## Researcher topics

- [Hair Growth and Disorders](https://scholariq.org/topics/hair-growth-and-disorders/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Facial Rejuvenation and Surgery Techniques](https://scholariq.org/topics/facial-rejuvenation-and-surgery-techniques/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)

## Researcher university

- [Novartis (United States)](https://scholariq.org/institutions/novartis-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.